Cargando…

Tyrosine Phosphorylation of the K(v)2.1 Channel Contributes to Injury in Brain Ischemia

In brain ischemia, oxidative stress induces neuronal apoptosis, which is mediated by increased activity of the voltage-gated K(+) channel K(v)2.1 and results in an efflux of intracellular K(+). The molecular mechanisms underlying the regulation of K(v)2.1 and its activity during brain ischemia are n...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Min-Young, Hwang, Ji Yeon, Bae, Eun Ji, Kim, Saesbyeol, Kang, Hye-Min, Kim, Yong Jun, Park, Chan, Park, Kang-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765428/
https://www.ncbi.nlm.nih.gov/pubmed/33333928
http://dx.doi.org/10.3390/ijms21249538
Descripción
Sumario:In brain ischemia, oxidative stress induces neuronal apoptosis, which is mediated by increased activity of the voltage-gated K(+) channel K(v)2.1 and results in an efflux of intracellular K(+). The molecular mechanisms underlying the regulation of K(v)2.1 and its activity during brain ischemia are not yet fully understood. Here this study provides evidence that oxidant-induced apoptosis resulting from brain ischemia promotes rapid tyrosine phosphorylation of K(v)2.1. When the tyrosine phosphorylation sites Y124, Y686, and Y810 on the K(v)2.1 channel are mutated to non-phosphorylatable residues, PARP-1 cleavage levels decrease, indicating suppression of neuronal cell death. The tyrosine residue Y810 on K(v)2.1 was a major phosphorylation site. In fact, cells mutated Y810 were more viable in our study than were wild-type cells, suggesting an important role for this site during ischemic neuronal injury. In an animal model, tyrosine phosphorylation of K(v)2.1 increased after ischemic brain injury, with an observable sustained increase for at least 2 h after reperfusion. These results demonstrate that tyrosine phosphorylation of the K(v)2.1 channel in the brain may play a critical role in regulating neuronal ischemia and is therefore a potential therapeutic target in patients with brain ischemia.